GLP-1 Receptor Agonist Market Size, Share & Growth Forecast Report 2024–2032
The GLP-1 Receptor Agonist Market is experiencing significant growth, fuelled by the rising global prevalence of type 2 diabetes and obesity, as well as major pharmaceutical innovations. Valued at USD 43.79 billion in 2023, the market is projected to reach USD 193.56 billion by 2032, growing at a CAGR of 17.61% over the forecast period (2024–2032). GLP-1 receptor agonists, originally developed for glycemic control, are now widely adopted for their dual role in glucose regulation and weight reduction—making them critical in both diabetes and obesity management.